- Country: Ukraine
- Summary: The Reagent is Intended for Quantitative in Vitro Determination of Glucose in Serum and Blood Plasma, as Well as in Human Urine, Nk 024:2023: 53301 - Glucose Ivd (In Vitro Diagnostics), Set, Enzyme Spectrophoto...
- UAT Ref No: 133364669
- Deadline: 15 Jan 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 280300
- Notice Type: Tender
- Document Ref. No.: UA-2026-01-07-005756-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The reagent is intended for quantitative in vitro determination of glucose in serum and blood plasma, as well as in human urine, NK 024:2023: 53301 - Glucose IVD (in vitro diagnostics), set, enzyme spectrophotometric analysis, NK 031:2024: W01010213 - GLUCOSE; Cuvettes for coagulometer Coag 4D, NK 024:2023: 61032 - Cuvette for laboratory IVD analyzer (in vitro diagnostics) for single use, NK 031:2024: W0503010203 - Sample analyses, plastic cuvettes; D-dimer Dia-D-Dimer or equivalent, NK 024:2023: 47349 - D-dimer IVD (in vitro diagnostics), reagent, NK 031:2024: W0103020503 - D-DIMER; Π ΠΎΠ·ΡΠΈΠ½ Π΄Π»Ρ ΠΏΡΠΎΠΌΠΈΠ²Π°Π½Π½Ρ Diaclean-SYS Π°Π±ΠΎ Π΅ΠΊΠ²ΡΠ²Π°Π»Π΅Π½Ρ, ΠΠ 024:2023: 63377 - ΠΠ°ΡΡΠ± ΠΎΡΠΈΡΠ΅Π½Π½Ρ ΠΏΡΠΈΠ»Π°Π΄Ρ/Π°Π½Π°Π»ΡΠ·Π°ΡΠΎΡΠ° ΠΠΠ, ΠΠ 031:2024: W0202020185 - ΠΠΎΠ°Π³ΡΠ»ΠΎΠΌΠ΅ΡΡΠΈ - Π²ΠΈΡΡΠ°ΡΠ½Ρ ΠΌΠ°ΡΠ΅ΡΡΠ°Π»ΠΈ; Π ΠΎΠ·ΡΠΈΠ½ Π΄Π»Ρ ΠΏΡΠΎΠΌΠΈΠ²Π°Π½Π½Ρ Coag Cleaner Π°Π±ΠΎ Π΅ΠΊΠ²ΡΠ²Π°Π»Π΅Π½Ρ, ΠΠ 024:2023: 63377 - ΠΠ°ΡΡΠ± Π΄Π»Ρ ΠΎΡΠΈΡΠ΅Π½Π½Ρ ΠΏΡΠΈΠ»Π°Π΄Ρ/ Π°Π½Π°Π»ΡΠ·Π°ΡΠΎΡΠ° IVD (Π΄ΡΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° in vitro), ΠΠ 031:2024: W0202020185 - ΠΠΎΠ°Π³ΡΠ»ΠΎΠΌΠ΅ΡΡΠΈ - Π²ΠΈΡΡΠ°ΡΠ½Ρ ΠΌΠ°ΡΠ΅ΡΡΠ°Π»ΠΈ; Kit for determination of fibrinogen, NK 024:2023: 55997 - Fibrinogen (factor I) IVD (in vitro diagnostics), set, analysis of clot formation, NC 031:2024: W0103020201 - Tests for fibrinogen (factor I); Glucose F set for determining the concentration of glucose, NK 024:2023: 53301 - Glucose IVD, set, enzymatic spectrophotometric analysis, NK 031:2024: W01010213 - GLUCOSE; Kit for determination of syroglycoides (syromucoids) in blood serum by the turbidimetric method, NK 024:2023: 59074 - Determination of IVD chromogen (diagnosis in v... Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 β Pharmaceutical products Qualification criteria of the procurement procedure Latest revisionHistory of changes Not required DK 021:2015: 33600000-6 β Pharmaceutical products Qualification criteria of the procurement procedure Latest revisionHistory of changes Not required
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINThe Reagent is Intended for Quantitative in Vitro Determination of Glucose in Serum and Blood Plasma, as Well as in Human Urine, Nk 024:2023: 53301 - Glucose Ivd (In Vitro Diagnostics), Set, Enzyme Spectrophoto... - Ukraine Tender
The MUNICIPAL NON-COMMERCIAL ENTERPRISE CHERNIGIV CITY HOSPITAL #2 OF CHERNIGIV CITY COUNCIL, a Government sector organization in Ukraine, has announced a new tender for The Reagent is Intended for Quantitative in Vitro Determination of Glucose in Serum and Blood Plasma, as Well as in Human Urine, Nk 024:2023: 53301 - Glucose Ivd (In Vitro Diagnostics), Set, Enzyme Spectrophoto.... This tender is published on UkraineTenders under UAT Ref No: 133364669 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-01-15.
The estimated tender value is UAH 280300, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
